Physician profile
Michael R Johnson
NPI 1730422791
$5,542.77
in general payments reported to CMS, 2019-2025
13 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,691 · 2020: $29.64 · 2021: $77.53 · 2022: $29.97 · 2023: $330 · 2024: $533 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,888.50 | 2019 | |
| Alpha Orthopedic Systems | $654.56 | 2019-2020 | |
| Acumed LLC | $569.00 | 2023-2025 | Osteomed, Acumed, Acumed |
| Stryker Corporation | $416.77 | 2021-2025 | Ortholoc 3di, Valor |
| Treace Medical Concepts, INC. | $377.40 | 2024-2025 | |
| Integra Lifesciences Corporation | $174.35 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Wright Medical Technology, INC. | $115.41 | 2019 | |
| Ethicon US, LLC | $111.37 | 2025 | Stratafix |
| Epsfl, LLC | $90.85 | 2023 | |
| Paragon 28, INC. | $49.14 | 2023-2024 | Portfolio, Bun-Yo-Matic |
| Amgen INC. | $48.90 | 2019-2020 | |
| Kci USA, INC. | $33.29 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Misonix INC | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.